Baxter trades at low valuations with 8x forward cash earnings, debt reduction, cost controls, margin expansion, and $50 2027 ...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced data in collaboration with The University of Texas ...
Data shared in collaboration with The University of Texas Medical Branch, representing an analysis of more than one million intravenous (IV) infusions using Baxter’s Spectrum IQ large volume infusion ...
Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced data in collaboration with The University of Texas Medical Branch (UTMB Health) ...
Baxter International Inc. and its executives allegedly misled shareholders about systemic safety issues with its new IV fluid pump, which eventually led the company to halt sales, causing a stock drop ...
Hosted on MSN
Pump training for 50 days led to massive gains
Superhuman Troy does pump training for 50 days and shows the massive gains he achieved. Congress clinches $1.2T funding deal for DHS, Pentagon, domestic agencies Another sphere is planned for US. Here ...
Baxter International Inc. (NYSE:BAX) Q2 2025 Earnings Call Transcript July 31, 2025 Baxter International Inc. misses on earnings expectations. Reported EPS is $0.59 EPS, expectations were $0.6.
Baxter saw its stock price plunge by more than 20% after it lowered its revenue projections for the remainder of this year, while reporting persistent expenses related to recovering from last fall’s ...
In the second quarter, Baxter turned in 1% operational sales growth and 28% adjusted EPS growth. Also, management reduced its guidance for 2025, including operational sales growth of 3% to 4% (down ...
IRVING, Texas--(BUSINESS WIRE)--Vizient ® announced today the expansion of the Vizient Reserve Program to include IV fluids through a strategic partnership with Baxter, a leading global medtech ...
Two people have died and 79 others have been seriously injured in potential association with a safety issue involving Baxter's Novum IQ large-volume infusion pumps. FDA said it is aware that Deerfield ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback